# Evaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)

> **NCT05417464** · NA · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 250 (estimated)

## Conditions studied

- Valvular Heart Disease

## Interventions

- **OTHER:** Use of flowchart

## Key facts

- **NCT ID:** NCT05417464
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-21
- **Primary completion:** 2024-02-21
- **Final completion:** 2024-03-21
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05417464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05417464, "Evaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05417464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*